Health And Medicine / Drug, Bio-affecting And Body Treating Compositions / 25 Or More Peptide Repeating Units In Known Peptide Chain Structure

	Methods of treatment using Alzheimer's amyloid polypeptide derivatives
	Mammalian antibiotic peptides
	Immunotherapy for recurrent HSV infections
	Materials and methods for treatment of plaquing disease
	Materials and methods for treatment of plaquing diseases
	Aβ peptides that modulate β-amyloid aggregation
	Treatment of multiple sclerosis by oral administration of autoantigens
	Compositions and methods for stimulating amyloid removal in amyloidogenic diseases using advanced glycosylation endproducts
	Huchordin and uses thereof
	Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
	Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
	Leishmania antigens for use in the therapy and diagnosis of leishmaniasis
	Delivery of drugs to the lower GI tract
	Embodiments of natural and synthetic lethal toxin neutralizing factors and their utility as treatment for envenomation
	Lethal toxin neutralizing factors
	Mutants of human antithrombin III
	Pegylated obese (ob) protein compositions
	OB polypeptides as modulators of body weight
	Mutant human growth hormones and their uses
	Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein
	Use of a non-mammalian DNA virus to express an exogenous gene in a mammalian cell
	Use of a non-mammalian DNA virus to express an exogenous gene in a mammalian cell
	Expression of an exogenous gene in a mammalian cell by use of a non-mammalian DNA virus having an altered coat protein
	Method for preventing embryo implantation
	Method of converting a drug to an orally available form by covalently bonding a lipid to the drug
	Prodrugs for oral administration containing taxol or substituted taxol covalently bound to a phospholipid
	Mixed amylin activity compounds
	Calcitonin derivatives
	Pharmaceutical compositions containing amylin
	Treatment of diabetes mellitus with amylin agonists
	Treatment of type 2 diabetes mellitus
	Methods and compositions for treatment of diabetes mellitus, hypoglycemia, and other conditions
	Methods for treating renin-related disorders with amylin antagonists
	Amylin agonist peptides and uses therefor
	Methods for regulating gastrointestinal motility
	Corticotropin releasing factor 2 receptor agonists
	Anti-inflammatory compositions and method with corticotropin-releasing factor analogs
	Synthetic IL-10 analogues
	Peptides and compounds that bind to the IL-5 receptor
	Reversible protease inhibitors
	Reversible cysteine protease inhibitors
	Human recombinant interleukin-2 muteins
	Therapeutic agents which are antagonists or partial agonists of human interleukin 4
	Radiolabeled proteins for diagnostic or therapeutic use
	TGF-βformulation for inducing bone growth
	Contraceptive methods and formulations for use therein
	Treatment of ovarian estrogen dependent conditions
	Pharmaceutical compositions for the nasal delivery of compounds useful for the treatment of osteoporosis
	Vascular endothelial cell growth factor C subunit
	Synthetic polypeptide fragments
	Type-specific opsonic antibodies evoked with a synthetic peptide of streptococcal M protein conjugated to polylysine without adjuvant